Providence is taking special steps during this flu season to protect people who face increased risk if exposed to the flu virus. Visitors are limited to people over age 12, with some exceptions. Read more ›
Brendan D. Curti, M.D., focuses on developing immunotherapies to treat malignancies of the prostate, kidney and bladder.
Providence Thoracic Oncology Program emphasizes a multidisciplinary approach to cancer management. Our clinical trials program offers a broad array of innovative clinical research, including studies of new surgical techniques, radiation, chemotherapy, targeted therapy and immunotherapy agents, and tissue banking. Rachel E. Sanborn, M.D., specializes in thoracic oncology and clinical research, studying new agents or combinations in the treatment of lung cancer, mesothelioma and other thoracic tumors.
Patients can access the latest heart and vascular therapies, which are currently available only through clinical research studies.